Editorial
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Stem Cells. Nov 26, 2011; 3(11): 96-103
Published online Nov 26, 2011. doi: 10.4252/wjsc.v3.i11.96
Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine
Xu-Yong Sun, Jiang Nong, Ke Qin, Garth L Warnock, Long-Jun Dai
Xu-Yong Sun, Jiang Nong, Ke Qin, Institute of Transplant Medicine, 303 Hospital of Chinese People’s Liberation Army, Nanning 530021, The Guangxi Zhuang Autonomous Region, China
Garth L Warnock, Long-Jun Dai, Department of Surgery, University of British Columbia, Vancouver, BC V5Z 1L8, Canada
Author contributions: Sun XY, Nong J, Qin K and Warnock GL wrote the manuscript; Dai LJ wrote and reviewed the manuscript.
Supported by Guangxi Ministry of Science and Technology, Juvenile Diabetes Research Foundation (No. 1-2008-474), VGH and UBC Hospital Foundation
Correspondence to: Long-Jun Dai, MD, PhD, Department of Surgery, University of British Columbia, 400-828 West 10 th Avenue, Vancouver, BC V5Z 1L8, Canada. ljdai@mail.ubc.ca
Telephone: +1-604-8754111-62501 Fax: +1-604-8754376
Received: July 12, 2011
Revised: October 23, 2011
Accepted: October 29, 2011
Published online: November 26, 2011
Core Tip